Apogee Therapeutics Inc (APGE)
EBITDA Growth
-27.68%
Quarterly · Period ending:
APGE EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-27.68%period ending
Latest reported-27.68%period ending
APGE Quarterly EBITDA YoY % (-126.57% → -27.68%)
Year-over-year change
High-resolution chart · PNG
APGE ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -27.6754% | |
| -33.7427% | |
| -2.6742% | |
| -31.8236% | |
| -94.2718% | |
| -71.6794% | |
| -111.5141% | |
| -134.9808% | |
| -24,209.0226% | |
| -126.5653% |